Daxor Corporation, CEO Michael Feldschuh to Participate in Maxim Group’s COVID-19 Virtual Conference on May 27, 2020
May 26, 2020 16:50 ET
|
Daxor Corporation
NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
DAXOR CORPORATION ANNOUNCES RISE IN KIT SALES AND FILES FORM N-CSR FOR 2019
March 02, 2020 07:55 ET
|
Daxor Corporation
NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
New Research Further Demonstrates Clinical Superiority of Daxor Corporation’s Blood Volume Analyzer (BVA-100®) in Critical Care
February 20, 2020 08:30 ET
|
Daxor Corporation
NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Newly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Hypertension
September 24, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice
May 30, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation to Exhibit at the Society of Hospital Medicine (SHM) Annual Conference 2019
March 22, 2019 08:30 ET
|
Daxor Corporation
NEW YORK , March 22, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Announces Rise in Kit Sales and Files Form N-CSR For 2018
March 04, 2019 08:30 ET
|
Daxor Corporation
NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
New Data Demonstrating the Clinical Utility of Daxor’s BVA-100 in Hypertension Management to be Presented at the American Heart Association’s Scientific Sessions 2018
November 08, 2018 13:46 ET
|
Daxor Corporation
Daxor to Exhibit at American Heart Association 2018 NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation...
Daxor Corporation Initiates Strategic Collaboration with CHF Solutions, Inc. to Manage Patients with Fluid Overload
November 01, 2018 08:30 ET
|
Daxor Corporation
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (NYSE MKT: DXR) announced today that it has entered into an agreement with CHF Solutions (Nasdaq: CHFS) to explore clinical synergies...
Daxor Corporation Appoints Robert J. Michel as Chief Financial Officer
September 28, 2018 08:30 ET
|
Daxor Corporation
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...